DOW Combat Readiness, Medical Research Program Translational Research Award

About this funding opportunity

Summary: The fiscal year 2026 (FY26) Combat Readiness, Medical Research Program (CRRP) Translational Research Award (TRA) supports hypothesis-driven innovative, high-impact translational research that will accelerate the movement of promising ideas and/or technologies in trauma care into solutions to maximize casualty survivability, improve patient care closer to the point of injury and/or trauma care guidelines. Preliminary data are required. Research using well-validated animal models is allowed.

Distinctive Features:

• NEW for FY26 An investigator may be named as the Principal Investigator (PI) on only one FY26 CRRP TRA application.

• Research supported by the FY26 CRRP TRA must represent a mature, translational research effort with a minimum biomedical technology readiness level (TRL) of 4 or knowledge readiness level (KRL) of 4.

Topic areas: General and Cross-cutting R&D, Life Sciences and Health, Security and Defense.

Funding amount

This cooperative agreement provides Varies in funding.

Deadline

Applications are due Nov 18, 2026. Confirm the exact closing time on the official program page before applying.

Who can apply

This opportunity is open to the following applicant types:

• Open to all applicant types

Eligibility

The program did not publish a separate eligibility statement. See the official opportunity page for the full eligibility criteria.

Agency

DOW Combat Readiness, Medical Research Program Translational Research Award is administered by Defense Health Agency Contracting Activity - DHACA (AMRAA), listed via Grants.gov.